Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Full-Year 2024 Guidance
The company reaffirms its full-year revenue guidance on a constant currency basis. After adjusting for the $75 million impact of the strengthening US dollar since February 12, 2024, the revenue guidance is now $15,325 million to $15,575 million on a reported basis, resulting in growth of 2.3 to 3.9 percent. This guidance represents a year-over-year foreign exchange headwind of ~100 basis points, versus the ~50 basis points headwind included in the previous guidance. This guidance continues to assume approximately $300 million of COVID-related revenue step down as well as ~100 basis points of contribution from acquisitions.
The company reaffirms its full-year Adjusted EBITDA guidance of $3,700 million to $3,800 million, representing growth of 3.7 to 6.5 percent.
The company reaffirms its full-year Adjusted Diluted EPS guidance of $10.95 to $11.25, up 7.4 to 10.3 percent year-over-year.
All financial guidance assumes foreign currency exchange rates as of April 30, 2024 remain in effect for the forecast period.
Posted In: IQV